Dr. Agarwal's Health Care Management
Management criteria checks 2/4
Dr. Agarwal's Health Care's CEO is Adil Agarwal, appointed in Jan 2019, has a tenure of 6.08 years. total yearly compensation is ₹48.60M, comprised of 93.2% salary and 6.8% bonuses, including company stock and options. directly owns 5.85% of the company’s shares, worth ₹7.52B. The average tenure of the management team and the board of directors is 1 years and 4.1 years respectively.
Key information
Adil Agarwal
Chief executive officer
₹48.6m
Total compensation
| CEO salary percentage | 93.2% |
| CEO tenure | 6.1yrs |
| CEO ownership | 5.9% |
| Management average tenure | 1yr |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹871m |
| Jun 30 2024 | n/a | n/a | ₹851m |
| Mar 31 2024 | ₹49m | ₹45m | ₹831m |
| Mar 31 2023 | ₹38m | ₹34m | ₹941m |
| Mar 31 2022 | ₹21m | ₹11m | ₹377m |
| Mar 31 2021 | ₹13m | ₹4m | -₹555m |
Compensation vs Market: Adil's total compensation ($USD559.39K) is about average for companies of similar size in the Indian market ($USD494.93K).
Compensation vs Earnings: Adil's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Adil Agarwal (41 yo)
6.1yrs
Tenure
₹48,600,000
Compensation
Dr. Adil Agarwal serves as Chief Executive Officer at Dr. Agarwal's Eye Hospital Limited and serves as its Whole -Time Director from 2024. Dr. Agarwal serves as Chief Executive Officer at Dr Agarwal’s Heal...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Whole-Time Director | 6.1yrs | ₹48.60m | 5.85% ₹ 7.5b | |
| COO & Wholetime Director | no data | ₹49.20m | 6.99% ₹ 9.0b | |
| VP of Corporate Affairs | no data | ₹6.80m | 0.0071% ₹ 9.1m | |
| Chief Financial Officer | less than a year | no data | 0.023% ₹ 29.1m | |
| Chief Clinical Officer | less than a year | no data | 5.11% ₹ 6.6b | |
| Chief Business Officer | 1yr | no data | 0.16% ₹ 200.6m | |
| Chief Strategy Officer | 1yr | no data | no data | |
| Chief Operating Officer- Hospital Operations | 2.8yrs | no data | 0.027% ₹ 35.0m |
1.0yrs
Average Tenure
40yo
Average Age
Experienced Management: AGARWALEYE's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Whole-Time Director | 8.8yrs | ₹48.60m | 5.85% ₹ 7.5b | |
| COO & Wholetime Director | 11.1yrs | ₹49.20m | 6.99% ₹ 9.0b | |
| Non-Executive Independent Director | 5.4yrs | ₹300.00k | no data | |
| Non-Executive Independent Director | less than a year | no data | no data | |
| Non-Executive Chairperson | 8.1yrs | no data | 5.64% ₹ 7.3b | |
| Non-Executive Independent Director | less than a year | no data | no data | |
| Non-Executive Nominee Director | 2.8yrs | no data | no data | |
| Non-Executive Independent Director | less than a year | no data | no data | |
| Non-Executive Nominee Director | 2.8yrs | no data | no data | |
| Non-Executive Independent Director | 8.4yrs | ₹300.00k | no data |
4.1yrs
Average Tenure
54.5yo
Average Age
Experienced Board: AGARWALEYE's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/12 12:10 |
| End of Day Share Price | 2025/02/12 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Agarwal's Health Care Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.